Pathophysiology and treatment of atherosclerosis : Current view and future perspective on lipoprotein modification

S C Bergheanu1,2, M C Bodde3, J W Jukema4

  • 1Centre for Human Drug Research, Leiden, The Netherlands.

Insights

This review covers new findings in atherosclerosis, focusing on how lipoprotein particles like LDL-C, HDL-C, TG, and Lp(a) contribute to plaque formation and how new drugs target these pathways.

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Pharmacology

Background:

  • Atherosclerosis pathogenesis and current treatment strategies are evolving.
  • Understanding lipoprotein particle roles in plaque formation is improving.
  • Recent clinical trials offer insights into novel therapeutic agents.

Purpose of the Study:

  • To review current knowledge on atherosclerosis pathophysiology and treatment.
  • To discuss emerging drug classes targeting atherosclerosis.
  • To focus on key lipid targets: LDL-C, HDL-C, TG, and Lp(a).

Main Methods:

  • Literature review of recent findings in atherosclerosis.
  • Analysis of cardiovascular clinical trial data.
  • Synthesis of current understanding and future perspectives on novel therapies.

Main Results:

  • Enhanced understanding of lipoprotein particle involvement in atherosclerotic plaque development.
  • Evaluation of the efficacy and safety of novel compounds targeting atherosclerosis pathways.
  • Identification of key lipid targets for therapeutic intervention.

Conclusions:

  • Novel therapeutic strategies targeting specific lipoproteins show promise for managing atherosclerosis.
  • Continued research into lipid metabolism and cardiovascular complications is crucial.
  • Personalized medicine approaches may optimize treatment for atherosclerotic disease.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
540
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.7K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
789
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
538
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
469